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Background: Nowadays, the increasing number of oncologic patients with liver or pancreatic tumours are
subjected to surgical treatment, as it can provide a long-term survival or sometimes cure. As a result, numerous
new clinical questions regarding metabolic disturbances in these patients have been arisen. Among others, the
impact of the pancreas and liver surgery extent in relation to the thyroid function remains to be elucidated.
Materials and methods: The study comprised 51 patients (25 men and 26 women, mean age ± SD 61.6 ± 10.4 yrs,
mean ± SD) with pancreatic or liver tumours, qualified for abdominal operation. Serum levels of FT3, FT4 and TSH
were measured on the day before (time “0”) and on the 1st, 3rd and 5th day after surgery in two (2) subgroups
reflecting the extent of surgery: twenty seven (27) patients (14 men and 13 women, mean age ± SD 61.5 ± 11.8 yrs)
after major surgery (Whipple’s surgery, right and left hemihepatectomy, segmentectomy of the liver, distal
pancreatectomy, total duodenopancreatectomy) and twenty four (24) patients (11 men and 13 women, mean age
± SD 61.8 ± 8.9 yrs) after minor, palliative surgery (exploratory laparotomy, gastroenterostomy, triple by-pass, liver
tumour embolization, hepaticojejunostomy). Additionally, the obtained results were analyzed in relation to the type
of the disease (pancreatic surgery vs liver surgery).
Results: Mean serum FT3 level decreased significantly during the study in major and minor surgery subgroups
(p<0.001, in both) in comparison to the baseline values, accompanied by stable serum concentrations of TSH (NS)
and FT4 (NS). The above decreasing tendency in FT3 concentrations was similar in both subgroups (NS), the same as
were unchanged levels of TSH (NS) and FT4 (NS). Mean FT4 concentration on the 3rd and 5th day after major surgery
was lower in pancreatic tumour patients in comparison to liver tumour patients (p=0.002, p=0.032, respectively).
Similarly, mean FT3 concentration on the 3rd day in minor surgery subgroup was lower in pancreatic tumour
patients in comparison to liver tumour patients (p=0.015).
Discussion: Our findings have confirmed essential reduction of FT3 values after abdominal surgery, independently
of surgery extent. Additionally, pancreatic tumour patients are more likely to have lower FT3 and FT4 levels after
surgery when compared to liver tumour patients.
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The condition called “low 3,5,30-triiodothyronine (T3)
syndrome” or “nonthyroidal illness syndrome (NTI)” or
“euthyroid sick syndrome” is characterized by low circu-
lating triiodothyronine (T3) levels without an initial rise
in thyroid stimulating hormone (TSH) in critically ill
patients [1,2]. Additionally, if the severity of illness
increases, there is a decrease in both serum T3 and thy-
roxine (T4) [3]. Abnormalities in thyroid hormone me-
tabolism reflect the severity of illness or trauma what
speaks in favor of the concept that these syndromes can
be used for prognostic purposes [2,4,5].
It is well known that the surgery causes complex meta-
bolic alterations and affects circulating thyroid hormone
concentrations, as well [6,7]. However, the potential im-
pact of various surgical procedures on the thyroid func-
tion remains not sufficiently clear.
Nowadays, the increasing number of oncologic
patients with liver or pancreatic tumours are subjected
to surgical treatment, as it can provide a long-term sur-
vival or sometimes cure. As a result, many new clinical
questions regarding metabolic disturbances in these
patients have been arisen.
In order to evaluate the effect of the pancreas and liver
surgery extent on the thyroid function, we measured free
T3 (FT3), free T4 (FT4) and thyrotropin (TSH) concen-
trations before and right after major and minor abdom-
inal surgery, looking for possible changes. Purposefully,
we have not decided to perform more complicated thy-
roid function tests such as reverse T3 and T3 resin up-
take, in hope of finding correlation between the extent
of liver and pancreas surgery and thyroid hormone levels
alterations measured by tests routinely available in all
laboratories.
Materials and methods
The study was approved by the Ethics Committee of
Medical University of Lodz, Poland. We investigated
serum samples collected from 51 patients (25 men and
26 women, mean age ± SD 61.6 ± 10.4 yrs) with pan-
creas or liver tumours, qualified for abdominal oper-
ation. The patients recruited to the study did not have
any known or clinically suspected thyroid dysfunction.
Additional exclusion criterion was treatment with thy-
roid hormones or antithyroid drugs. The patients were
divided into two (2) subgroups reflecting the extent of
surgery. Twenty seven (27) patients (14 men and 13
women, mean age ± SD 61.5 ± 11.8 yrs) with resectable
tumours underwent major surgery: Whipple’s surgery
(n=13), right and left hemihepatectomy (n=6), segmen-
tectomy of the liver (n=4), distal pancreatectomy (n=3)
or total duodenopancreatectomy (n=1). Twenty four
(24) patients (11 men and 13 women, mean age ± SD
61.8 ± 8.9 yrs) with unresectable tumours underwentminor, palliative surgery: exploratory laparotomy (n=9),
gastroenterostomy in unresectable pancreatic tumours
(n=6), triple by-pass (n=4), liver tumour embolization
(n=4) and hepaticojejunostomy (n=1).
Serum concentrations of FT3, FT4 and TSH were
measured on the day before surgery (time “0”), and also
on the 1st, 3rd and 5th day after surgery. Additionally, the
obtained results were analyzed in relation to the type of
the disease (pancreatic surgery vs liver surgery).
We have used a one way repeated measures analysis of
variance for comparison of mean concentrations of
TSH, FT3 and FT4 in four (4) measurements. We have
employed the Fisher LSD method for comparison of
FT3 concentrations in each subsequent measurement in
relation to blood collection time point, before and after
surgery, respectively. In order to compare the differences
in TSH serum concentrations between patients who
underwent minor and major abdominal surgery, we have
applied the parametric t-test and non-parametric Mann-
Whitney’s and Kruskal-Wallis’ tests. The t-test, equal
variance test and Holm-Sidak method have been per-
formed for demonstration differences in FT3 and FT4
concentrations between aforementioned groups. Fur-
thermore, Mann-Whitney’s and equal variance tests have
been carried out to compare TSH, FT3 and FT4 after
liver and pancreas surgery in two (2) previously analyzed
subgroups. In all analyses, statistical significance has
been considered achieved at a value of p<0.05.
All statistical calculations and graphs have been per-
formed using SigmaPlot version 12.0 (Systat Software
Inc., San Jose, CA, USA).Results
Mean values of FT3, FT4 and TSH on the following days
are presented in Table 1 and Table 2. Mean serum FT3
level decreased significantly during the study in major
(Figure 1) and minor (Figure 2) surgery subgroups in
comparison to time “0” values (p<0.001, in each case),
accompanied by unchanged serum level of TSH (NS)
and FT4 (NS). The above decreasing tendency in FT3
concentrations was similar in both subgroups (NS), the
same as were unchanged levels of TSH (NS) and FT4
(NS).
In the group of patients with pancreatic tumours who
underwent major surgery it was found that FT4 concen-
tration was lower on the 3rd day (1.082 ± 0.144) than in
subjects with liver tumours (mean ± SD 1.272 ± 0.108)
(p=0.002). Similar differences were observed on the 5th
day (median 1.035 vs 1.185) (p=0.032).
In the group of subjects after the minor operation,
FT3 concentration on the 3rd day after the surgery was
lower in the patients with pancreatic disease (1.629 ±
0.458) than in the patients with liver tumours (mean ±
Table 1 Mean values of FT3, FT4 and TSH concentrations on the subsequent days in major and minor surgery
subgroups
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statistically significant.
Discussion
Despite the description of low T3 syndrome above 40
years ago, its pathogenesis has not been completely
understood. Various parameters have been considered to
play role in this syndrome, including inhibitors of T3 or
T4 binding to proteins, decreased deiodinase 1 (D1), and
deiodinase 2 (D2) activities and increased deiodinase 3Table 2 Mean values of FT3, FT4 and TSH concentrations on t
patients’ subgroups
Major surgery subgroup
Pancreatic tumor patients Liver tu
N 17 10








TSH [mIU/L] N: 0.35-4.94 0 1.258 1.152
1 1.277 0.971
3 1.080 1.302
5 1.445 1.239(D3) activity, as well as are tumour necrosis factor α
(TNFα), interleukin 6 (IL-6) [8]. In addition, one of the
dilemmas is the significance of low T3 syndrome in crit-
ically ill patients. Some researchers demonstrated a pro-
tective function of that phenomenon [9], while others
reported rather as either an adaptive process in the con-
dition of reduced energy supplies or a maladaptive one,
resulting in tissues impairment [10].
When discussing the low T3 syndromes, it should be
mentioned that this phenomenon occurs immediatelyhe subsequent days in pancreatic and liver tumor
Minor surgery subgroup
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p<0.001
Figure 1 FT3 serum concentration in the major surgery subgroup on the subsequent days. Upper and lower limits of boxes are 75 and 25
percentile, respectively. Horizontal line in boxes represents mean value. Whiskers illustrate SD.
Wojciechowska-Durczynska et al. Thyroid Research 2012, 5:21 Page 4 of 6
http://www.thyroidresearchjournal.com/content/5/1/21after operation due to stress [7]. Disturbances of thyroid
function can be observed within the first hours after skin
incision [8]. Furthermore, patients with low T3 level
were older than those with normal T3 level and in case
of critically ill patients, low T3 syndrome was much
more frequently found in the non-survivors than in sur-
vivors; consequently, the case fatality rate (CFR) was
much higher in the group of patients with low T3 level
than in patients with normal T3 [11].
Our findings have confirmed reduction of FT3 values
on 1st, 3rd, 5th day after surgery in both studied groups,
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p<0.001
Figure 2 FT3 serum concentration in the minor surgery subgroup on
percentile, respectively. Horizontal line in boxes represents mean value. Whrange only in 3rd and 5th day after major surgery. Thus,
our observations are in compliance with previous studies
that proved the presence of low T3 syndrome in patients
after minimally invasive laparoscopic cholecystectomy
[7] and after major cardiopulmonary bypass surgery
[12,13]. Additionally, just as expected, patients with
low T3 concentrations before surgery demonstrated
postoperatively a more severe degree of low T3 syn-
drome [12].
The comparable results of thyroid function tests in two
analyzed subgroups provide some evidence that the ex-
tent of abdominal surgery does not impact significantly    3   5 [days]
the subsequent days. Upper and lower limits of boxes are 75 and 25
iskers illustrate SD.
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agreement with prior study [14] in which surgical proce-
dures were divided into minor, moderate and extensive
surgery and - likewise in our study - on the 1st day after
surgery serum FT3 levels decreased in all 3 groups, when
compared to the baseline values. Serum FT4 levels did
not change regardless of surgical procedure [14]. How-
ever, certain discrepancy exists between previous quoted
results and our observations. In opposite to our findings,
Murai et al. [14] demonstrated that serum TSH levels
decreased significantly on 1st day after surgery in the
groups of moderate and extensive surgery.
It is worth stressing that in the our study patients who
underwent minor surgery, mainly palliative due to unre-
sectable abdominal tumours, were in the worse general
condition before operation than patients who underwent
major surgery. In our opinion, this fact - together with
surgery extent - influenced the thyroid hormone metab-
olism and resulted in the similar final thyroid condition
in both subgroups. This suggestion stays in accordance
with results of earlier study in which authors demon-
strated that the abnormalities in thyroid hormone me-
tabolism were more frequent in patients admitted for
urgent surgery than in patients scheduled for elective
surgery. Furthermore, half out of the patients who
underwent urgent surgery, persisted with changes in thy-
roid function tests in the late postoperative period,
whereas most of the patients submitted to elective sur-
gery presented an improvement in their thyroid function
in the same period of time [6]. These results could indi-
cate that the low T3 syndrome rather reflects the ser-
iousness of patient’s general condition than the impact
of surgery.
Our further statistical analyses revealed lower mean
FT3 and FT4 concentrations after surgery in pancreatic
tumours patients when compared to liver tumours
patients. It is tempting to speculate that novel finding
could be explained by an increased proportion of free
thyroid hormones after liver surgery, caused by lower
thyroid hormone binding proteins concentrations (hypo-
proteinemia) [15,16]. Another explanation might be
based on an assumption that pancreatic surgery – gener-
ally - is a more serious procedure with more serious
complications and lower free thyroid hormones levels
are known to be a manifestation of particularly deep and
serious metabolic disturbances.
Furthermore, it is worth mentioning that low T3 syn-
drome early after partial hepatectomy, characterized by
increased activity of D3, associated with low serum and
liver thyroid hormone levels, has been proved to have
important role in the regenerating liver, in which a de-
crease in cellular T3 promotes an increase in prolifera-
tion [17]. The last cited report supports the hypothesis
that low T3 syndrome is an adaptive process.In order to make discussion on our results completed,
we have to recall that although the extent of abdominal
surgery does not impact significantly on the thyroid
function, patients after pancreatic surgery are more
likely to reveal lower FT4 levels.
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